EcoDrugPlus

Tubulin, Alpha 7 Like

Ensembl ID : ENSOKIG00005045533
Gene Symbol: TUBA7L
1 Cross references
310 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSOKIG00005043880
Gene Symbol: TP53
3 Cross references
160 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSOKIG00005034140
Gene Symbol: TYR
3 Cross references
195 Possible Orthologues:

Tyrosinase-Like

Ensembl ID : ENSOKIG00005009538
Gene Symbol: LOC109909722
3 Cross references
201 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSOKIG00005011268
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSOKIG00005029215
Gene Symbol: TYK2
1 Cross references
190 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSOKIG00005028483
Gene Symbol: TYK2
3 Cross references
190 Possible Orthologues:

Tyrosine-Protein Kinase Fyn

Ensembl ID : ENSOKIG00005008681
Gene Symbol: LOC109900669
3 Cross references
140 Possible Orthologues:

Tyrosine-Protein Kinase Fyn

Ensembl ID : ENSOKIG00005016693
Gene Symbol: LOC109866316
3 Cross references
189 Possible Orthologues:

Tyrosine-Protein Kinase Hck-Like

Ensembl ID : ENSOKIG00005027500
Gene Symbol: LOC109907963
2 Cross references
196 Possible Orthologues:

Tyrosine-Protein Kinase Jak1-Like

Ensembl ID : ENSOKIG00005030483
Gene Symbol: LOC109898129
3 Cross references
205 Possible Orthologues:

Tyrosine-Protein Kinase Jak2

Ensembl ID : ENSOKIG00005039463
Gene Symbol: LOC109877853
3 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).